Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The burden of childhood and adolescent cancers in North Africa and the Middle East (NAME) region: findings from the Global Burden of Disease study 2019.
Karimi A, Saeedi Moghaddam S, Azadnajafabad S, Esfahani Z, Sharifnejad Tehrani Y, Abbasi-Kangevari M, Shobeiri P, Ghamari SH, Masinaei M, Rezaei N, Shahin S, Rayzan E, Rezaei N, Larijani B, Kompani F. Karimi A, et al. Among authors: rayzan e. BMC Pediatr. 2023 Mar 8;23(1):113. doi: 10.1186/s12887-023-03931-4. BMC Pediatr. 2023. PMID: 36890483 Free PMC article.
Regional and national burden of leukemia and its attributable burden to risk factors in 21 countries and territories of North Africa and Middle East, 1990-2019: results from the GBD study 2019.
Heidari-Foroozan M, Saeedi Moghaddam S, Keykhaei M, Shobeiri P, Azadnajafabad S, Esfahani Z, Rezaei N, Nasserinejad M, Rezaei N, Rayzan E, Shokri Varniab Z, Golestani A, Haghshenas R, Kompani F, Larijani B, Farzadfar F. Heidari-Foroozan M, et al. Among authors: rayzan e. J Cancer Res Clin Oncol. 2023 Jul;149(8):4149-4161. doi: 10.1007/s00432-022-04293-7. Epub 2022 Sep 1. J Cancer Res Clin Oncol. 2023. PMID: 36048271
Novel DNMT3B Mutation in a Patient with Immunodeficiency, Centromeric Instability, and Facial Anomalies (ICF) Syndrome and a Bronchopulmonary Collateral Artery.
Aminorroaya A, Rayzan E, Shahkarami S, Seyedpour S, Zoghi S, Aryan Z, Somekh I, Rohlfs M, Klein C, Esmaeilzadeh H, Rezaei N. Aminorroaya A, et al. Among authors: rayzan e. Endocr Metab Immune Disord Drug Targets. 2023;23(3):410-415. doi: 10.2174/1871530322666220822141722. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 35996251
Case Report of a Novel NFkB Mutation in a Lymphoproliferative Disorder Patient.
Danandeh K, Jabbari P, Rayzan E, Zoghi S, Shahkarami S, Heredia RJ, Krolo A, Shamsian BS, Boztug K, Rezaei N. Danandeh K, et al. Among authors: rayzan e. Endocr Metab Immune Disord Drug Targets. 2022;22(10):1040-1046. doi: 10.2174/1871530322666220407091356. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35392793
A 3-Year-Old Boy with an Xp21 Deletion Syndrome: A Case Report.
Sadeghmousavi S, Shahkarami S, Rayzan E, Ahmed S, Gharalari FH, Rohlfs M, Klein C, Rezaei N. Sadeghmousavi S, et al. Among authors: rayzan e. Endocr Metab Immune Disord Drug Targets. 2022;22(8):881-887. doi: 10.2174/1871530322666220201143656. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35105298
28 results